FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2886313023> ?p ?o ?g. }

• W2886313023 abstract "Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, is a highly aggressive tumor with a 5-year survival of <6%. While surgery is the only curative treatment for PDAC patients, the majority of patients present with advanced disease and are ineligible for resection. These patients usually receive gemcitabine, and have a median survival of ~6 months. Identification of novel targets and development of effective therapies are imperative to improve outcome for patients with this tumor type.We and others document that inhibiting the function of BET bromodomain proteins suppresses PDAC tumor growth in preclinical models. The BET family of proteins is characterized by two N-terminal bromodomains, BD1 and BD2, which bind to acetylated lysine residues on specific histones. The binding of BET proteins to acetylated lysines promotes the formation of transcriptional complexes, and impacts gene transcription and chromatin structure. The literature suggests the potential specific roles for BD1 vs BD2 using pharmacological inhibitors and dominant negative mutational analyses. However, the relative importance of each bromodomain with respect to transcriptional regulation compared to chromatin structure is not well understood. Further, there is suggestion in the literature that each bromodomain function may differ in specific tumor cell types. Functional differences between BD1 and BD2 in PDAC cells have not been reported.The goal of the current study was to compare the efficacy of the BD2-specific BET inhibitor (BETi) SJ018 with the efficacy of the pan-BET inhibitor I-BET762 in PDAC cells. We exposed four PDAC cell lines (Panc1, BxPC3, MiaPaCa2, and CFPAC) to a range of concentrations of SJ018 or I-BET762 for 96 hours, and assessed cell viability using alamarBlue. Data, analyzed using GraphPad Prism 7, demonstrated that SJ018 exerted up to ~60-fold lower IC50 values across all cell lines tested compared to the pan-BET inhibitor I-BET762.Further, we recently made a novel observation that the pan-BETi JQ1 induced DNA damage and inhibits expression of the DNA repair protein Rad51 in PDAC cells. Immunoblot analysis for phosphorylated Ser-139 H2AX (γH2AX), a marker of DNA damage, demonstrated that SJ018 and I-BET762 also increased DNA damage, and that the BD2-specific SJ018 induces DNA damage to a greater extent and at a lower dose than the BD1/BD2 inhibitor I-BET762 in BxPC3 cells. The data also showed that both SJ018 and I-BET762 inhibited expression of the homologous recombination protein Rad51 in vitro. We conclude that SJ018 is more potent than I-BET762 in PDAC cells as a single agent, and that degree of potency is reflected by higher levels of DNA damage.Citation Format: Aubrey Lynn Miller, Peter J. Slavish, Brandon M. Young, Philip M. Potter, Anang A. Shelat, Karina J. Yoon. Targeting the BD2 BET bromodomain to inhibit proliferation of pancreatic ductal adenocarcinoma cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 5794." @default.
• W2886313023 created "2018-08-22" @default.
• W2886313023 creator A5006044181 @default.
• W2886313023 creator A5028692847 @default.
• W2886313023 creator A5032991502 @default.
• W2886313023 creator A5078320545 @default.
• W2886313023 creator A5088338902 @default.
• W2886313023 creator A5089104332 @default.
• W2886313023 date "2018-07-01" @default.
• W2886313023 modified "2023-09-26" @default.
• W2886313023 title "Abstract 5794: Targeting the BD2 BET bromodomain to inhibit proliferation of pancreatic ductal adenocarcinoma cells" @default.
• W2886313023 doi "https://doi.org/10.1158/1538-7445.am2018-5794" @default.
• W2886313023 hasPublicationYear "2018" @default.
• W2886313023 type Work @default.
• W2886313023 sameAs 2886313023 @default.
• W2886313023 citedByCount "0" @default.
• W2886313023 crossrefType "proceedings-article" @default.
• W2886313023 hasAuthorship W2886313023A5006044181 @default.
• W2886313023 hasAuthorship W2886313023A5028692847 @default.
• W2886313023 hasAuthorship W2886313023A5032991502 @default.
• W2886313023 hasAuthorship W2886313023A5078320545 @default.
• W2886313023 hasAuthorship W2886313023A5088338902 @default.
• W2886313023 hasAuthorship W2886313023A5089104332 @default.
• W2886313023 hasConcept C104317684 @default.
• W2886313023 hasConcept C119157956 @default.
• W2886313023 hasConcept C121608353 @default.
• W2886313023 hasConcept C126322002 @default.
• W2886313023 hasConcept C185592680 @default.
• W2886313023 hasConcept C2779634854 @default.
• W2886313023 hasConcept C2780210213 @default.
• W2886313023 hasConcept C2780258809 @default.
• W2886313023 hasConcept C2780862049 @default.
• W2886313023 hasConcept C41091548 @default.
• W2886313023 hasConcept C502942594 @default.
• W2886313023 hasConcept C55493867 @default.
• W2886313023 hasConcept C62112901 @default.
• W2886313023 hasConcept C64927066 @default.
• W2886313023 hasConcept C71924100 @default.
• W2886313023 hasConcept C74401373 @default.
• W2886313023 hasConcept C83640560 @default.
• W2886313023 hasConcept C86803240 @default.
• W2886313023 hasConceptScore W2886313023C104317684 @default.
• W2886313023 hasConceptScore W2886313023C119157956 @default.
• W2886313023 hasConceptScore W2886313023C121608353 @default.
• W2886313023 hasConceptScore W2886313023C126322002 @default.
• W2886313023 hasConceptScore W2886313023C185592680 @default.
• W2886313023 hasConceptScore W2886313023C2779634854 @default.
• W2886313023 hasConceptScore W2886313023C2780210213 @default.
• W2886313023 hasConceptScore W2886313023C2780258809 @default.
• W2886313023 hasConceptScore W2886313023C2780862049 @default.
• W2886313023 hasConceptScore W2886313023C41091548 @default.
• W2886313023 hasConceptScore W2886313023C502942594 @default.
• W2886313023 hasConceptScore W2886313023C55493867 @default.
• W2886313023 hasConceptScore W2886313023C62112901 @default.
• W2886313023 hasConceptScore W2886313023C64927066 @default.
• W2886313023 hasConceptScore W2886313023C71924100 @default.
• W2886313023 hasConceptScore W2886313023C74401373 @default.
• W2886313023 hasConceptScore W2886313023C83640560 @default.
• W2886313023 hasConceptScore W2886313023C86803240 @default.
• W2886313023 hasLocation W28863130231 @default.
• W2886313023 hasOpenAccess W2886313023 @default.
• W2886313023 hasPrimaryLocation W28863130231 @default.
• W2886313023 hasRelatedWork W1592012543 @default.
• W2886313023 hasRelatedWork W1994476636 @default.
• W2886313023 hasRelatedWork W2199675338 @default.
• W2886313023 hasRelatedWork W2345014259 @default.
• W2886313023 hasRelatedWork W2409927883 @default.
• W2886313023 hasRelatedWork W2760514844 @default.
• W2886313023 hasRelatedWork W2911436634 @default.
• W2886313023 hasRelatedWork W2950081633 @default.
• W2886313023 hasRelatedWork W2981488738 @default.
• W2886313023 hasRelatedWork W3012724360 @default.
• W2886313023 isParatext "false" @default.
• W2886313023 isRetracted "false" @default.
• W2886313023 magId "2886313023" @default.
• W2886313023 workType "article" @default.